Olema Pharmaceuticals Inc.
OLMA | NASDAQ
$9.64
-$0.18 (-1.83%)
At close: Sep 21, 2026, 4:00 PM ET
$9.81
+$0.17 (+1.76%)
Pre-market:
Sep 22, 2026, 5:49 AM ET
Market Data
Market Cap $857.75M
Enterprise Value $381.44M
Beta 1.99
Average Volume 1.28M
Shares Outstanding (Diluted) 104.45M
Shares Change YoY 22.17%
Institutional Ownership 98.71%
Exchange NASDAQ
ISIN US68062P1066
Price Performance
Price Change 1M -8.9%
Price Change 3M -8.4%
Price Change 6M -32.0%
Price Change YTD -61.9%
Price Change 1Y 15.7%
Price Change 3Y -22.8%
Price Change 5Y -66.1%
1M CAGR (ann.) -16.8%
1Y CAGR (ann.) 26.7%
5Y CAGR (ann.) -19.6%
All-Time CAGR -24.1%
Valuation
PE Ratio -4.53
Forward PE N/A
PEG Ratio 0.90
Forward PEG -0.41
PS Ratio N/A
Forward PS 102.80
PB Ratio 1.96
P/FCF Ratio -5.11
P/Adj. FCF Ratio -4.52
P/OCF Ratio -6.10
EV/Sales N/A
EV/EBIT -1.86
EV/EBITDA -1.87
EV/FCF -2.32
Earnings Yield -22.1%
FCF Yield -19.6%
Adj. FCF Yield -22.1%
Financial Health
Net Cash $460.41M
Total Debt $660K
Cash & Short-Term Investments $461.07M
Total Assets $486.58M
Current Ratio 8.86
Quick Ratio 8.86
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt -249.60
Interest Coverage 0.00
Altman Z-Score 6.77
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -13.0%
Returns
Return on Assets -42.0%
Return on Equity -48.2%
Return on Invested Capital -50.9%
Return on Capital Employed -51.0%
Return on Tangible Assets -42.0%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y -1.4%
EPS CAGR 5Y 3.6%
EPS CAGR 10Y N/A
FCF CAGR 3Y -28.2%
FCF CAGR 5Y -20.7%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 9
EPS Growth Next 3Y 8.0%
Revenue Growth Next 3Y N/A
Earnings Date Nov 8, 2026
EPS Estimate (next Q) -$0.60
EPS Growth Est (next Q) 22.4%
Revenue Est (next Q) $1.25M
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $28.33
Price Target Upside 193.9%
Cash Flow
Operating Cash Flow $-164.74M
Free Cash Flow $-164.74M
Adj. Free Cash Flow $-186.16M
FCF Per Share -$1.58
OCF Per Share -$1.58
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $-306K
Operating Income $-221.13M
EBITDA $-204M
Net Income $-204.57M
EPS (Diluted) -$2.13
Revenue / Employee N/A
Profit / Employee $-1.36M
Employees 150
Add to Watchlist
Select watchlists to add or remove OLMA